Anti-Aripiprazole - (Clone ARI-0079) - 1.0 mg

Primary Monoclonal Antibodies

2 - 8°C Wet Ice

Aripiprazole, a third-generation atypical antipsychotic, is commonly prescribed for thetreatment of schizophrenia, bipolar disorder, and major depressive disorder. Introducedin the early 21st century, aripiprazole exhibits a distinctive mechanism of action as apartial agonist at dopamine D2 and serotonin 5-HT1A receptors, while antagonizingserotonin 5-HT2A receptors. This unique pharmacological profile contributes to itsefficacy in balancing dopamine and serotonin levels in the brain, alleviating symptomsassociated with various psychiatric conditions. Unlike many antipsychotics, aripiprazoleis associated with a lower risk of metabolic side effects. Close monitoring of sideeffects in the first few weeks of drug administration is required and therapeutic drugmonitoring may be considered in certain situations to ensure optimal dosing.

≥1.0 mg/ml